Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Patent for AI-powered safety monitoring of medical devices granted in Indonesia

Brighter has been granted its patent for computer driven supervision of the health of portable medical devices in Indonesia. The patent has previously been granted in South Korea and parts of Europe. The patent ensures rights to a system that enables AI-powered supervision of the functionality of mobile medical equipment with injection apparatus, such as the company's diabetes management device Actiste, to decide whether the device needs to be repaired, serviced or replaced. “For patient-safety reasons, it is of great importance that injection devices work in a correct and reliable

Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)

The shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company” or “Moberg Pharma”) are hereby convened to the Extraordinary General Meeting on Tuesday, 28 April 2020 at 4:30 p.m. (CET) in the Company’s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden.Attendance at the Extraordinary General Meeting Shareholders who wish to participate in the Extraordinary General Meeting must: · be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”), on Wednesday, 22 April 2020, and · give notice of attendance

Information about the COVID-19 impact on Raketech

Raketech, the iGaming performance marketing partner, monitors the development of the COVID-19 virus and its potential effects on its industry closely. So far, the strategies as how to handle the outbreak have been different from country to country which makes the situation somewhat hard to predict. Raketech do not anticipate substantial negative effects on the iGaming industry in the long term, even though sports betting revenues most likely will be affected negatively during 2020 due to the many cancelled sports events. Q1 2020 is so far delivering revenues in line with expectations with

World-leading hospital Mayo Clinic orders SyntheticMR’s solution for clinical routine

SyntheticMR announced today that they have received a purchase order from Mayo Clinic for its medical imaging software solution SyMRI.Mayo Clinic is ranked the No. 1 hospital in the US and receives more than 1.2 million patients from all 50 states. The purchase order relates to SyntheticMR’s product SyMRI for use in clinical routine, which will support shorter scan times while providing more information to the clinician. “I see great potential in quantitative MRI and SyMRI as a product,” says Dr Wende Gibbs, Neuroradiologist at Mayo Clinic. “The ability to add multi-parametric maps and

Investor AB postpones the Annual General Meeting

Due to the current situation with high uncertainty and several changes in a short period of time relating to the rapid spread of covid-19, Investor’s Board of Directors has decided to postpone the Annual General Meeting (AGM). This is done in order to further evaluate the situation and its potential effects on the Board’s proposal to the AGM, such as the proposal of dividend.  The AGM was scheduled for May 5, 2020 at City Conference Center in Stockholm.  Investor will publish a new invitation to the AGM no later than four weeks prior to the new date. The AGM will at the latest be held

Redeye: Strax - Low Market Expectations

Redeye lowers its short-term expectations on Strax due to the corona-crisis. Our long-term view of the case remains optimistic, with an experienced team managing the business and a vast distribution network providing a competitive edge. On the back of a solid Q4'19-report and a share price decline of 50% during March, we identify an attractive opportunity for the long-term investor. Read more and download the research update: https://bit.ly/2Jl3MBf Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release

DDM Debt AB publishes its 2019 Annual report

DDM Debt AB (Nasdaq Stockholm: DDM2) today published its 2019 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch. A printed copy can be ordered via the website or by mail: investor@ddm-group.ch  DDM Debt currently intends to publish financial information on the following dates in 2020:   Interim report January – March 2020: 7 May 2020 Annual General Meeting: 23 June 2020 Interim report January – June 2020: 30 July 2020 Interim report January – September 2020: 5 November 2020   This is information which DDM Debt AB is obliged to

Director & PDMR Dealing

27 March 2020   Independent Oil and Gas plc Director & PDMR Dealing   Independent Oil and Gas plc ("IOG" or the "Company"), the development and production company focused on becoming a substantial UK gas producer, is pleased to announce that certain Directors and persons discharging managerial responsibilities ("PDMRs") of the Company have purchased in the market 320,000 ordinary shares of 1p each at an average price of 11.87p per share in the Company, equating to an aggregate value of £37,973.87. Share purchases and revised shareholdings are shown below: Director/ Role

DDM Holding AG publishes its 2019 Annual report

DDM Holding AG (First North: DDM) today published its 2019 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch. A printed copy can be ordered via the website or by mail: investor@ddm-group.ch  DDM currently intends to publish financial information on the following dates in 2020:   Interim report January – March 2020: 7 May 2020 Annual General Meeting: 23 June 2020 Interim report January – June 2020: 30 July 2020 Interim report January – September 2020: 5 November 2020   This is information which DDM Holding AG is obliged to make

Invitation to the Annual General Meeting of Boliden AB (publ)

The shareholders of Boliden AB (publ) (company registration number 556051-4142) are summoned to the Annual General Meeting to be held on Tuesday, April 28, 2020 at 4.00 p.m. (CET). The Annual General Meeting will be held at Posthuset, Vasagatan 28, in Stockholm. The meeting room will open for registration from 3.30 p.m.Given the current situation with COVID-19 (coronavirus), Boliden has decided to put health and safety first and hold the meeting in Stockholm instead of Aitik, Gällivare, as was previously planned, and to shorten the meeting as much as possible. Registration will therefore

‘The Foundation’ expansion for critically acclaimed ‘Control’ serves more stylish supernatural action on PS4 and PC today

Remedy Entertainment Plc | Press release 9:00 am (EET) 27 March 2020 ‘The Foundation’ expansion for critically acclaimed ‘Control’ serves more stylish supernatural action on PS4 and PC today 505 Games and Remedy Entertainment Invite Players to a New Sector of the Oldest House Control  is “Action Game of the Year ” (Academy of Interactive Arts & Sciences D.I.C.E. Awards) and developer Remedy Entertainment  have injected more pulse-pounding

Viking Line: Postponement of General Meeting, Change in dividend proposal, and proposal for new board composition.

Viking Line Abp                         NOTICE OF GENERAL MEETING                March 27, 2020, 9.00 AM.                                                          POSTPONEMENT OF GENERAL MEETING, CHANGE IN DIVIDEND PROPOSAL, AND PROPOSAL FOR NEW BOARD COMPOSITION With reference to the Company’s Year-end Report of February 13, 2020, and the Company’s Annual Report published March 6, 2020, it is hereby announced that Viking Line Abp’s Board of Directors has decided to postpone this year’s ordinary General Meeting to a time that will be announced in a separate notice. The Board has

Preliminary figures for the first quarter indicate strong growth for Nexam Chemical and extends the subscription period in the ongoing rights issue

Nexam Chemical experienced a strong development during the first quarter and sales are expected to amount to approximately SEK 40 million (SEK 31.7 million), which is the strongest quarter in the company's history. EBITDA is estimated to amount to about SEK 2 million (SEK -1.7 million). Following the announcement of the quarterly result, Nexam Chemical extends the subscription period in the ongoing rights issue until Thursday, April 2, 2020.Sales of SEK 40 million correspond to a growth of 26 percent, which is mainly driven by continued strong development within the business area

Annual General Meeting of Shareholders in Securitas AB

The shareholders of Securitas AB, reg. no 556302-7241, are hereby invited to attend the Annual General Meeting (“AGM”) to be held at 16.00 CEST on Thursday May 7, 2020 at Courtyard Marriott Hotel, Rålambshovsleden 50, Stockholm. Further information regarding the process of entry will be made available on the company website www.securitas.com/agm2020.A.    Notice of attendanceShareholders who wish to attend the AGM must: (i)    be recorded in the share register maintained by Euroclear Sweden AB on Thursday April 30, 2020; and (ii)    notify Securitas AB of their intent to participate

Reduced costs by SEK 200 million when Serneke streamlines the organization

Serneke takes the next step in a large reorganization that the company initiated in the fall of 2019. The changes now being implemented leads to reduced costs of about SEK 200 million annually. Expected to be in full effect at the beginning of 2021 and to impact up to 100 positions.“The measures we are now implementing lead to an adjustment of the cost base for the new Serneke Sweden and its more efficient working methods. In addition, the current situation in the world with the effects of covid-19 requires additional acuity and decisiveness”, says Ola Serneke, acting CEO of Serneke Sweden

FlexQube´s annual report 2019 available on the website

Press Release 2020-03-27, 08:00 CET FlexQube´s annual report 2019 has today been published on FlexQube´s website and can be downloaded at: https://www.flexqube.com/uploads/c/bf/flexqube-rsredovisning2019.pdf The financial year covers the period from 1 January to 31 December 2019. The annual report will also be translated to English and is planned to be published on a later date.  About FlexQube FlexQube is a company that offers a unique and patented concept that is used to design and deliver robust, modular and flexible carts and racks. The company has manufacturing in

Gradientech receives SEK 6.3M from BIO-X® Accelerate program

Uppsala, March 27, 2020. Gradientech has been awarded with SEK 6.3M from the highly competitive BIO-X Accelerate program, to support the commercialization journey of its diagnostic system QuickMIC®. QuickMIC is an ultra-rapid system designed to provide fast and targeted treatment for sepsis patients.In the challenging times we are facing, the need for innovative, life-saving infection diagnostics is higher than ever before. Due to the emergence of the new coronavirus (COVID-19) pandemic, older people and those with chronic conditions are now at a higher risk of contracting severe illnesses

Atrium Ljungberg is hosting a presentation of Q1 Report 2020 on 16 April at 10.00 CET

Atrium Ljungberg is hosting an online broadcast of the Q1 Report 2020 presentation at 10.00 CET on 16 April 2020. The Q1 report 2020 will be published at 7.30 CET on the same day. Equity analysts, investors, media and other stakeholders are invited to participate in the conference where CEO Annica Ånäs and CFO Martin Lindqvist will present the results for Q1 2020. The presentation will be held in English and can be watched online using the following link: https://tv.streamfabriken.com/en-atrium-ljungberg-q1-2020 After the broadcast, the presentation and written material can be

There are no items matching the current filter
There are no more items matching the current filter
Back to top